Literature DB >> 8808733

Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei.

P M Rodier1, J L Ingram, B Tisdale, S Nelson, J Romano.   

Abstract

The underlying brain injury that leads to autism has been difficult to identify. The diagnostic criteria of the disease are not readily associated with any brain region or system, nor are they mimicked by vascular accidents, tumors, or degenerative neurological diseases occurring in adults. Fortuitously, a recent report of autism induced by thalidomide exposure provides evidence that the disease originates by an injury at the time of closure of the neural tube. The human data suggest that the initiating lesion includes the motor cranial nerve nuclei. To test this hypothesis, we first examined motor nuclei in the brainstem of a human autistic case. The autopsy brain exhibited near-complete absence of the facial nucleus and superior olive along with shortening of the brainstem between the trapezoid body and the inferior olive. A similar deficit has been reported in Hoxa-1 gene knockout mice in which pattern formation of the hindbrain is disrupted during neurulation. Alternatively, exposure to antimitotic agents just after neural tube closure could produce the observed pattern of deficits. Thus, the lesions observed in the autopsy case appear to match those predicted by the thalidomide cases in both time of origin and central nervous system (CNS) location. To produce similar brain lesions experimentally, we exposed rat embryos to valproic acid, a second teratogen newly linked to autism. Dams received 350 mg/kg of valproic acid (VPA) on day 11.5 (the day of neural tube closure), day 12, or day 12.5 gestation. Each treatment significantly reduced the number of motor neurons counted in matched sections of the earliest-forming motor nuclei (V, XII), and progressively later exposures affected the VIth and IIIrd cranial nerve nuclei. All treatments spared the facial nucleus, which forms still later. Counts from the mesencephalic nucleus of trigeminal, the dorsal motor nucleus of the vagus, and the locus ceruleus were not affected by exposure to VPA, even though these nuclei form during the period when exposure occurred. Despite its effects on the motor nuclei, valproic acid exposure did not alter the further development of the brain in any obvious way. Treated animals were robust and had no external malformations. The autopsy data and experimental data from rats confirm that CNS injuries occurring during or just after neural tube closure can lead to a selective loss of neurons derived from the basal plate of the rhombencephalon. The results add two new lines of evidence that place the initiating injury for autism around the time of neural tube closure.

Entities:  

Mesh:

Year:  1996        PMID: 8808733     DOI: 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  150 in total

Review 1.  Turning heads: development of vertebrate branchiomotor neurons.

Authors:  Anand Chandrasekhar
Journal:  Dev Dyn       Date:  2004-01       Impact factor: 3.780

2.  Sensory and motor characterization in the postnatal valproate rat model of autism.

Authors:  Stacey Reynolds; Alexandre Millette; Darragh P Devine
Journal:  Dev Neurosci       Date:  2012-05-24       Impact factor: 2.984

3.  Genome-wide transcriptome profiling reveals the functional impact of rare de novo and recurrent CNVs in autism spectrum disorders.

Authors:  Rui Luo; Stephan J Sanders; Yuan Tian; Irina Voineagu; Ni Huang; Su H Chu; Lambertus Klei; Chaochao Cai; Jing Ou; Jennifer K Lowe; Matthew E Hurles; Bernie Devlin; Matthew W State; Daniel H Geschwind
Journal:  Am J Hum Genet       Date:  2012-06-21       Impact factor: 11.025

4.  Acute prenatal exposure to ethanol and social behavior: effects of age, sex, and timing of exposure.

Authors:  Sandra M Mooney; Elena I Varlinskaya
Journal:  Behav Brain Res       Date:  2010-08-20       Impact factor: 3.332

5.  Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study.

Authors:  Rebecca J Schmidt; Daniel J Tancredi; Sally Ozonoff; Robin L Hansen; Jaana Hartiala; Hooman Allayee; Linda C Schmidt; Flora Tassone; Irva Hertz-Picciotto
Journal:  Am J Clin Nutr       Date:  2012-05-30       Impact factor: 7.045

6.  Paternal sperm DNA methylation associated with early signs of autism risk in an autism-enriched cohort.

Authors:  Jason I Feinberg; Kelly M Bakulski; Andrew E Jaffe; Rakel Tryggvadottir; Shannon C Brown; Lynn R Goldman; Lisa A Croen; Irva Hertz-Picciotto; Craig J Newschaffer; M Daniele Fallin; Andrew P Feinberg
Journal:  Int J Epidemiol       Date:  2015-04-14       Impact factor: 7.196

7.  Autism with ophthalmologic malformations: the plot thickens.

Authors:  Marilyn T Miller; Kerstin Strömland; Liana Ventura; Maria Johansson; Jose M Bandim; Christopher Gillberg
Journal:  Trans Am Ophthalmol Soc       Date:  2004

8.  Alleviation of N-Methyl-D-Aspartate Receptor-Dependent Long-Term Depression via Regulation of the Glycogen Synthase Kinase-3β Pathway in the Amygdala of a Valproic Acid-Induced Animal Model of Autism.

Authors:  Han-Fang Wu; Po See Chen; Yi-Ju Chen; Chi-Wei Lee; I-Tuan Chen; Hui-Ching Lin
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

9.  Olfaction and taste processing in autism.

Authors:  Loisa Bennetto; Emily S Kuschner; Susan L Hyman
Journal:  Biol Psychiatry       Date:  2007-06-18       Impact factor: 13.382

Review 10.  From loci to networks and back again: anomalies in the study of autism.

Authors:  Ralph-Axel Müller
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.